Viread Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected Adults
Condition:   HIV Infections Intervention:   Drug: Biktarvy 50 mg/200 mg/25 mg film-coated tablets Sponsor:   Fundacion Clinic per a la Recerca Biomédica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2022 Category: Research Source Type: clinical trials